TWI304735B - Carbamate compounds for use in the treatment of pain - Google Patents

Carbamate compounds for use in the treatment of pain Download PDF

Info

Publication number
TWI304735B
TWI304735B TW091103502A TW91103502A TWI304735B TW I304735 B TWI304735 B TW I304735B TW 091103502 A TW091103502 A TW 091103502A TW 91103502 A TW91103502 A TW 91103502A TW I304735 B TWI304735 B TW I304735B
Authority
TW
Taiwan
Prior art keywords
pain
group
formula
mirror image
substituted
Prior art date
Application number
TW091103502A
Other languages
English (en)
Chinese (zh)
Inventor
R Plata-Salaman Carlos
Zhao Boyu
E Twyman Roy
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of TWI304735B publication Critical patent/TWI304735B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
TW091103502A 2001-02-27 2002-02-27 Carbamate compounds for use in the treatment of pain TWI304735B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27188801P 2001-02-27 2001-02-27
US10/081,943 US6815464B2 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in the treatment of pain

Publications (1)

Publication Number Publication Date
TWI304735B true TWI304735B (en) 2009-01-01

Family

ID=23037511

Family Applications (1)

Application Number Title Priority Date Filing Date
TW091103502A TWI304735B (en) 2001-02-27 2002-02-27 Carbamate compounds for use in the treatment of pain

Country Status (28)

Country Link
US (1) US6815464B2 (cg-RX-API-DMAC10.html)
EP (1) EP1404312B1 (cg-RX-API-DMAC10.html)
JP (1) JP4276838B2 (cg-RX-API-DMAC10.html)
KR (1) KR100906315B1 (cg-RX-API-DMAC10.html)
CN (1) CN1849116A (cg-RX-API-DMAC10.html)
AR (1) AR033427A1 (cg-RX-API-DMAC10.html)
AT (1) ATE493125T1 (cg-RX-API-DMAC10.html)
AU (1) AU2002254015B2 (cg-RX-API-DMAC10.html)
BR (1) BR0207673A (cg-RX-API-DMAC10.html)
CA (1) CA2439274C (cg-RX-API-DMAC10.html)
CY (1) CY1111349T1 (cg-RX-API-DMAC10.html)
CZ (1) CZ20032298A3 (cg-RX-API-DMAC10.html)
DE (1) DE60238765D1 (cg-RX-API-DMAC10.html)
DK (1) DK1404312T3 (cg-RX-API-DMAC10.html)
ES (1) ES2356617T3 (cg-RX-API-DMAC10.html)
HU (1) HUP0303236A3 (cg-RX-API-DMAC10.html)
IL (1) IL157593A0 (cg-RX-API-DMAC10.html)
MX (1) MXPA03007721A (cg-RX-API-DMAC10.html)
MY (1) MY129312A (cg-RX-API-DMAC10.html)
NO (1) NO20033804L (cg-RX-API-DMAC10.html)
NZ (1) NZ527994A (cg-RX-API-DMAC10.html)
PL (1) PL364647A1 (cg-RX-API-DMAC10.html)
PT (1) PT1404312E (cg-RX-API-DMAC10.html)
RS (1) RS67603A (cg-RX-API-DMAC10.html)
RU (1) RU2283106C2 (cg-RX-API-DMAC10.html)
TW (1) TWI304735B (cg-RX-API-DMAC10.html)
WO (1) WO2002067922A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA200307475B (cg-RX-API-DMAC10.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003007934A1 (en) * 2001-07-16 2003-01-30 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
EP1998781A2 (en) * 2006-03-24 2008-12-10 Wyeth a Corporation of the State of Delaware Treatment of pain
US20100160351A1 (en) * 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
WO2010071865A1 (en) 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
WO2011032175A1 (en) 2009-09-14 2011-03-17 Nuon Therapeutics, Inc. Combination formulations of tranilast and allopurinol and methods related thereto
EP2496227B1 (en) 2009-11-06 2019-05-22 SK Biopharmaceuticals Co., Ltd. Methods for treating fibromyalgia syndrome
ES2447295T3 (es) 2009-11-06 2014-03-11 Sk Biopharmaceuticals Co., Ltd. Métodos para el tratamiento del trastorno de déficit de atención/hiperactividad
US8623913B2 (en) 2010-06-30 2014-01-07 Sk Biopharmaceuticals Co., Ltd. Methods for treating restless legs syndrome
US9610274B2 (en) 2010-06-30 2017-04-04 Sk Biopharmaceuticals Co., Ltd. Methods for treating bipolar disorder
US9018253B2 (en) 2010-07-02 2015-04-28 Bio-Pharm Solutions Co., Ltd. Phenylcarbamate compound and muscle relaxant containing the same
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
CN102266317A (zh) * 2011-06-24 2011-12-07 中国人民解放军第三军医大学 丙戊酸及其衍生物的应用
RU2632659C2 (ru) * 2011-12-27 2017-10-09 Байо-Фарм Солюшнс Ко., Лтд. Фенилкарбаматные соединения для применения в предупреждении или лечении эпилепсии
JP6062077B2 (ja) 2013-03-12 2017-01-18 バイオ−ファーム ソリューションズ カンパニー リミテッド 小児てんかん及びてんかん関連症侯群の予防又は治療用フェニルカルバメート化合物{phenylcarbamatecompoundsforuseinpreventingortreatingpediatricepilesyandepilesy−relatedsyndromes}
KR102421013B1 (ko) * 2016-05-19 2022-07-14 에스케이바이오팜 주식회사 삼차신경통을 예방 또는 치료하기 위한 카바메이트 화합물의 용도

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3278380A (en) * 1962-02-06 1966-10-11 Armour Pharma Methods of calming employing diphenyl hydroxy carbamate compounds
US3265728A (en) 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
RU2020972C1 (ru) * 1991-02-07 1994-10-15 Мегдятов Рашид Салехович Способ лечения невралгии тройничного нерва
US5698588A (en) 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
ATE226071T1 (de) * 1996-10-08 2002-11-15 Ortho Mcneil Pharm Inc Antikonvulsive derivate zur behandlung von neuropathischem schmerz
GB2340074A (en) * 1998-08-01 2000-02-16 Max Imaging Systems Limited Printing process
PL365701A1 (en) 2000-07-21 2005-01-10 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain

Also Published As

Publication number Publication date
KR100906315B1 (ko) 2009-07-07
JP2004523553A (ja) 2004-08-05
CZ20032298A3 (cs) 2004-08-18
AU2002254015B2 (en) 2006-08-24
ATE493125T1 (de) 2011-01-15
NO20033804L (no) 2003-09-30
RU2003128984A (ru) 2005-03-20
CA2439274C (en) 2011-04-05
WO2002067922A1 (en) 2002-09-06
PL364647A1 (en) 2004-12-13
MXPA03007721A (es) 2004-11-12
KR20030076711A (ko) 2003-09-26
RU2283106C2 (ru) 2006-09-10
CA2439274A1 (en) 2002-09-06
JP4276838B2 (ja) 2009-06-10
NO20033804D0 (no) 2003-08-26
CY1111349T1 (el) 2015-08-05
EP1404312A1 (en) 2004-04-07
NZ527994A (en) 2005-11-25
US20020156127A1 (en) 2002-10-24
US6815464B2 (en) 2004-11-09
RS67603A (sr) 2007-02-05
MY129312A (en) 2007-03-30
EP1404312B1 (en) 2010-12-29
IL157593A0 (en) 2004-03-28
DK1404312T3 (da) 2011-03-14
AR033427A1 (es) 2003-12-17
DE60238765D1 (de) 2011-02-10
ZA200307475B (en) 2005-01-03
HUP0303236A3 (en) 2012-07-30
BR0207673A (pt) 2004-12-28
CN1849116A (zh) 2006-10-18
ES2356617T3 (es) 2011-04-11
PT1404312E (pt) 2011-02-01
HUP0303236A2 (hu) 2004-01-28

Similar Documents

Publication Publication Date Title
CN104662007B (zh) 胱硫醚‑γ‑裂合酶(CSE)抑制剂
CN1750839B (zh) 类辣椒素的给药
US6589986B2 (en) Methods of treating anxiety disorders
JP2022521446A5 (cg-RX-API-DMAC10.html)
JPS6084251A (ja) 鎮痛用新規化合物および組成物
TWI331524B (en) Carbamate compounds for use in preventing or treating movement disorders
JP4276838B2 (ja) 疼痛(pain)の治療における使用のためのカルバメート化合物
CA2999965A1 (en) Apilimod compositions and methods for using same
ES2649492T3 (es) (S)-pirlindol o sus sales farmacéuticamente aceptables para uso en medicina
JPH0920659A (ja) 炎症性腹部疾患のためのカッパ−アヘン製剤作働薬
TWI250872B (en) Carbamate compounds for use in preventing or treating bipolar disorder
AU2002254015A1 (en) Carbamate compounds for use in the treatment of pain
JPH02501070A (ja) 骨一消耗病の治療用医薬の組合せ
CN101569626B (zh) 使用巴比土酸衍生物治疗运动障碍的方法
CN102858176A (zh) 镇痛化合物、组合物及其应用
EA015483B1 (ru) ПРИМЕНЕНИЕ ИНГИБИТОРА p38 КИНАЗЫ ДЛЯ ЛЕЧЕНИЯ ПСИХИАТРИЧЕСКИХ РАССТРОЙСТВ
JP2008184396A (ja) 神経損傷に起因する身体機能障害の予防及び治療のための医薬
US11364218B2 (en) Method of treating or preventing mood disorders, mental disorders, and/or chronic fatigue syndrome
JPH02288823A (ja) 筋弛緩剤
RU2051674C1 (ru) Средство для лечения бруксизма
JP2006518722A (ja) 膵臓癌、軟部組織の肉腫、精巣腫瘍、リンパ腫、胸腺腫、ウィルムス腫瘍、腎臓癌、黒色腫、肺腫瘍、脳内転移、頭頸部の腫瘍、および乳癌の処置のための、1−(2−クロロエチル)−1−ニトロソ−3−(2−ヒドロキシエチル)ウレアの使用方法
WO2005011591A2 (en) Method for the treatment of sleep disorders
CN101242836A (zh) 改善觉醒状态的方法
UA63647A (en) Method for combined treatment of demodecosis
TH15814A (th) สารประกอบเฮเทอโรไซคลิค, การเตรียมสารเหล่านั้นและ?การใช้สารเหล่านั้น

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees